Qube Research & Technologies Ltd

Position in RVMD — Revolution Medicines, Inc.

CIK 1729829 LONDON, X0

Position in RVMD

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$58,874,277

+$5,066,825 QoQ

Shares Held

314,365

-43.2% QoQ

Ownership

0.147%

of shares outstanding

% of Portfolio

0.07%

of 13F equity value

Holder Rank

#79

of 687 holders

Holding Since

Sep 2023

10 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Qube Research & Technologies Ltd holds $2,443,042,063 across 169 Biotechnology names. RVMD ranks #12 (2.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ALNY	Alnylam Pharmaceuticals, Inc.	798,715	$240,437,176
2	INSM	INSMED Inc	1,682,334	$179,370,451
3	REGN	Regeneron Pharmaceuticals, Inc.	221,607	$138,180,828
4	ROIV	Roivant Sciences Ltd.	3,454,496	$122,254,613
5	AXSM	Axsome Therapeutics, Inc.	426,336	$104,354,262
6	APGE	Apogee Therapeutics, Inc.	659,678	$87,559,060
7	TVTX	Travere Therapeutics, Inc.	1,443,230	$81,989,896
8	RPRX	Royalty Pharma plc	1,412,112	$79,177,119

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$58,874,277	314,365	-43.2%	Shares	Sole	2026-08-14
2026-03-31	$53,807,452	553,290	-29.6%	Shares	Sole	2026-05-15
2025-06-30	$28,917,565	786,017	+329.2%	Shares	Sole	2025-08-14
2025-03-31	$6,475,830	183,140	-20.7%	Shares	Sole	2025-05-15
2024-12-31	$10,097,160	230,845	+61.3%	Shares	Sole	2025-02-14
2024-09-30	$6,488,405	143,074	-42.6%	Shares	Sole	2024-11-14
2024-06-30	$9,670,985	249,188	+48.8%	Shares	Sole	2024-08-14
2024-03-31	$5,397,879	167,480	+556.4%	Shares	Sole	2024-05-14
2023-12-31	$731,769	25,515	-88.3%	Shares	Sole	2024-02-13
2023-09-30	$6,046,197	218,432	—	Shares	Sole	2023-11-13
No filing history on record for this holder in this stock.